BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 32690000)

  • 1. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.
    Martire S; Nguyen J; Sundaresan A; Banaszynski LA
    BMC Mol Cell Biol; 2020 Jul; 21(1):55. PubMed ID: 32690000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic occupancy of the transcriptional co-activators p300 and CBP.
    Holmqvist PH; Mannervik M
    Transcription; 2013; 4(1):18-23. PubMed ID: 23131664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles for CBP and p300 on the RA-mediated expression of the meiosis commitment gene Stra8 in mouse embryonic stem cells.
    Chen W; Jia W; Wang K; Si X; Zhu S; Duan T; Kang J
    PLoS One; 2013; 8(6):e66076. PubMed ID: 23785470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.
    Raisner R; Kharbanda S; Jin L; Jeng E; Chan E; Merchant M; Haverty PM; Bainer R; Cheung T; Arnott D; Flynn EM; Romero FA; Magnuson S; Gascoigne KE
    Cell Rep; 2018 Aug; 24(7):1722-1729. PubMed ID: 30110629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14.
    Li X; Chen X; Zhou W; Ji S; Li X; Li G; Liu G; Wang F; Hao A
    Neuroscience; 2017 Nov; 364():45-59. PubMed ID: 28782640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
    Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
    Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.
    Wong CK; Wade-Vallance AK; Luciani DS; Brindle PK; Lynn FC; Gibson WT
    Diabetes; 2018 Mar; 67(3):412-422. PubMed ID: 29217654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.
    Lai B; Lee JE; Jang Y; Wang L; Peng W; Ge K
    Nucleic Acids Res; 2017 Jun; 45(11):6388-6403. PubMed ID: 28398509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair.
    Manickavinayaham S; Vélez-Cruz R; Biswas AK; Bedford E; Klein BJ; Kutateladze TG; Liu B; Bedford MT; Johnson DG
    Nat Commun; 2019 Oct; 10(1):4951. PubMed ID: 31666529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p300 and CBP disrupts histone acetylation at the mouse Sry promoter and causes XY gonadal sex reversal.
    Carré GA; Siggers P; Xipolita M; Brindle P; Lutz B; Wells S; Greenfield A
    Hum Mol Genet; 2018 Jan; 27(1):190-198. PubMed ID: 29145650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.
    Chakraborty R; Ostriker AC; Xie Y; Dave JM; Gamez-Mendez A; Chatterjee P; Abu Y; Valentine J; Lezon-Geyda K; Greif DM; Schulz VP; Gallagher PG; Sessa WC; Hwa J; Martin KA
    Circulation; 2022 Jun; 145(23):1720-1737. PubMed ID: 35502657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.
    Hsu E; Pennella MA; Zemke NR; Eng C; Berk AJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.
    Wang F; Marshall CB; Ikura M
    Cell Mol Life Sci; 2013 Nov; 70(21):3989-4008. PubMed ID: 23307074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBP and p300 are essential for renin cell identity and morphological integrity of the kidney.
    Gomez RA; Pentz ES; Jin X; Cordaillat M; Sequeira Lopez ML
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1255-62. PubMed ID: 19252086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide assessment of differential roles for p300 and CBP in transcription regulation.
    Ramos YF; Hestand MS; Verlaan M; Krabbendam E; Ariyurek Y; van Galen M; van Dam H; van Ommen GJ; den Dunnen JT; Zantema A; 't Hoen PA
    Nucleic Acids Res; 2010 Sep; 38(16):5396-408. PubMed ID: 20435671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation.
    Kasper LH; Lerach S; Wang J; Wu S; Jeevan T; Brindle PK
    EMBO J; 2010 Nov; 29(21):3660-72. PubMed ID: 20859256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes.
    Ogiwara H; Kohno T
    PLoS One; 2012; 7(12):e52810. PubMed ID: 23285190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.
    Fang F; Xu Y; Chew KK; Chen X; Ng HH; Matsudaira P
    Stem Cells; 2014 Jul; 32(7):1805-16. PubMed ID: 24648406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release.
    Narita T; Ito S; Higashijima Y; Chu WK; Neumann K; Walter J; Satpathy S; Liebner T; Hamilton WB; Maskey E; Prus G; Shibata M; Iesmantavicius V; Brickman JM; Anastassiadis K; Koseki H; Choudhary C
    Mol Cell; 2021 May; 81(10):2166-2182.e6. PubMed ID: 33765415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.